Original Article

Urine amino acid and gamma aminobutyric acid level in COVID 19 patients

Abstract

Background and Objectives: SARS CoV2 has tropism for various tissues, including the respiratory tract, brain, endothelium, heart, kidney and liver. Neurological symptoms can also be seen in the clinical course of the disease, and anosmia is the most common. The main objective of our study was to examine the urinary amino acid profiles of moderately severe patients diagnosed with COVID-19 with a positive RT-PCR test and try to find metabolic changes associated with the infection. Also, it was aimed to investigate the neuroinhibitory Gamma-Aminobutyric acid (GABA) levels in order to examine the physiopathology.
Materials and Methods: Thirty adult cases who were followed up in the infection clinic with positive SARS CoV 2 RT-PCR and diagnosed with COVID 19 disease were included in the study with consent. The amino acid profile of these patients' urine samples, 30 different amino acid levels and creatine levels were examined using the liquid chromatography-mass spectrometry (LCMS) method on the SCIEX QTRAP 4500 device.
Results: The mean age of the patients is 40 ± 5. Elevated GABA in 28/30 cases, high hydroxylysine amino acid in 27/30 cases, low glycine in 30/30 cases were detected in the urine. The creatinine levels of the patients were found to be normal.
Conclusion: It has been thought that the height of GABA may be due to bacteria producing GABA as a result of the change in microbiota due to lactic acidosis, as well as that the virus may directly affect the brain and cause an increase in GABA.

1. Ciotti M, Angeletti S, Minieri M, Giovannetti M, Benvenuto D, Pascarella S, et.al. COVID-19 Outbreak: An overview. Chemotherapy 2019; 64: 215-223.
2. Watson CJ, Thomas RH, Solomon T, Michael BD, Nicholson TR, Pollak TA. COVID-19 and psychosis risk: Real or delusional concern? Neurosci Lett 2021; 741: 135491.
3. Steardo L, Steardo L Jr, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) 2020; 229(3): e13473.
4. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; 87: 18-22.
5. Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological sequelae of COVID-19. J Integr Neurosci 2022; 21: 77.
6. Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol 2020; 70: 311-322.
7. Fan S, Xiao M, Han F, Xia P, Bai X, Chen H, et al. Neurological manifestations in critically Ill patients with COVID-19: A retrospective study. Front Neurol 2020; 11: 806.
8. Gromova OA, Torshin IY, Semenov VA, Putilina MV, Chuchalin AG. Direct and indirect Neurological signs of COVID-19. Neurosci Behav Physiol 2021; 51: 856-866.
9. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 277: 2251-2261.
10. Taenzer M, Löffler-Ragg J, Schroll A, Monfort-Lanzas P, Engl S, Weiss G, et al. Urine Metabolite analysis to identify Pathomechanisms of long COVID: A pilot study. Int J Tryptophan Res 2023; 16: 11786469231220781.
11. Rosolanka R, Liptak P, Baranovicova E, Bobcakova A, Vysehradsky R, Duricek M, et al. Changes in the urine metabolomic profile in patients Recovering from severe COVID-19. Metabolites 2023; 13: 364.
12. Marhuenda-Egea FC, Narro-Serrano J, Shalabi-Benavent MJ, Álamo-Marzo JM, Amador-Prous C, Algado-Rabasa JT, et al. A metabolic readout of the urine metabolome of COVID-19 patients. Metabolomics 2023; 19: 7.
13. Sherry EB, Lee P, Choi I-Y. In Vivo NMR Studies of the brain with Hereditary or acquired metabolic disorders. Neurochem Res 2015; 40: 2647-2685.
14. Büttiker P, Weissenberger S, Stefano GB, Kream RM, Ptacek R. SARS-CoV-2, trait Anxiety, and the microbiome. Front Psychiatry 2021; 12: 720082.
15. Masoodi M, Peschka M, Schmiedel S, Haddad M, Frye M, Maas C, et al. Disturbed lipid and amino acid metabolisms in COVID-19 patients. J Mol Med (Berl) 2022; 100: 555-568.
16. Bagheri SH, Asghari A, Farhadi M, Shamshiri AR, Kabir A, Kamrava SK, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Med J Islam Repub Iran 2020; 34: 62.
17. Pérez Álvarez ÁI, Suárez Cuervo C, Fernández Menéndez S. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies. Neurologia (Engl Ed) 2020; 35: 264-265.
18. Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, et al. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience. Muscle Nerve 2020; 62: 485-491.
19. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012; 113: 411-417.
20. Pokusaeva K, Johnson C, Luk B, Uribe G, Fu Y, Oezguen N, et al. GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine. Neurogastroenterol Motil 2017; 29(1): e12904.
21. Zareian M, Ebrahimpour A, Bakar FA, Mohamed AKS, Forghani B, Ab-Kadir MSB, et al. A glutamic acid-producing lactic acid bacteria isolated from Malaysian fermented foods. Int J Mol Sci 2012; 13: 5482-5497.
22. Siragusa S, De Angelis M, Di Cagno R, Rizzello CG, Coda R, Gobbetti M. Synthesis of gamma-aminobutyric acid by lactic acid bacteria isolated from a variety of Italian cheeses. Appl Environ Microbiol 2007; 73: 7283-7290.
23. Yang S-Y, Lü F-X, Lu Z-X, Bie X-M, Jiao Y, Sun L-J, et al. Production of gamma-aminobutyric acid by Streptococcus salivarius subsp. thermophilus Y2 under submerged fermentation. Amino Acids 2008; 34: 473-478.
24. Brennan GT. COVID-19-Induced collagenous colitis. Gastro Hep Adv 2022; 1: 976.
Files
IssueVol 17 No 1 (2025) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v17i1.17809
Keywords
COVID 19; Urin amino acids; Gamma-aminobutyric acid
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Kazezoglu C, İrvem A, Tuba Sutasir Y, Çakiroglu B, Kirgiz B, Yilmaz H, Kocatas A. Urine amino acid and gamma aminobutyric acid level in COVID 19 patients. Iran J Microbiol. 2025;17(1):122-127.